Michael Sperling, MD: The SLATE Trial in Epilepsy
January 29th 2019The Baldwin Keyes Professor of Neurology and director of the Jefferson Comprehensive Epilepsy Center at Thomas Jefferson University spoke about the trial of the Visualase MRI-guided laser ablation system and the unmet needs in epilepsy.
Using Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
January 28th 2019The chief of the Division of Immunotherapy at the Northwestern University Feinberg School of Medicine discussed the results of the randomized clinical trial and the implications of this treatment in clinical practice.
Patient View of Tourette Severity Related More to Functional Impairment Than Tic Noticeability
January 26th 2019The postgraduate epidemiology fellow at the Centers for Disease Control and Prevention discussed the data and what she and her colleagues found in their analyses of children with Tourette syndrome.
Challenges and Excitement in Alzheimer Disease
January 23rd 2019The director of the Center for Neurodegeneration and Translational Neuroscience and director emeritus, Cleveland Clinic Lou Ruvo Center for Brain Health, shared thoughts on his hope for the future of Alzheimer disease, among other topics.
Costantino Iadecola, MD: Cognitive Reserve in Alzheimer Disease
January 23rd 2019The Anne Parrish Titzell Professor of Neurology and Neuroscience at Weill Cornell Medicine’s Feil Family Brain and Mind Research Institute discussed how to make the decision about who will end developing Alzheimer and who will not when amyloid buildup occurs.
Seizure Worsening in Pregnancy, Postpartum is Influenced by Epilepsy Type
January 21st 2019The attending neurologist at Brigham and Women's Hospital spoke about data from an analysis that concluded that women with frontal lobe epilepsy are more likely to experience a worsening of their seizure frequency during pregnancy.
Ocrelizumab Shows Superiority in Treating Relapsing MS Over Other DMTs
January 21st 2019Several network meta-analyses have suggested that ocrelizumab is superior or comparable in its efficacy and safety to the other 14 available disease-modifying therapies in treating relapsing multiple sclerosis.
Perampanel as a Treatment for Secondarily Generalized Seizures
January 20th 2019The pediatric epileptologist at Nicklaus Children’s Hospital discussed the long-term seizure freedom data that looked at the effectiveness of perampanel which demonstrated a gratifying response in seizure control for patients with secondarily generalized seizures.